Ganymed Robotics, developer of computer vision software and robotics technologies for orthopedic surgeons, announced it has raised €21 million in the oversubscribed first close of its Series B funding. The round was led by Cathay Health, with participation of Credit Mutuel Innovation, Kurma Partners, BNP Paribas Développement and internationally renowned surgeons.
Hyperscience announced it raised $100 million in Series E funding led by existing investors Global Founders Capital, Tiger, Stripes, and Bessemer. The new round of investment enables Hyperscience, with nearly 400 global employees—a 72% increase year-over-year—to further invest in talent and R&D, both organically and through acquisition.
Bots & BusinessInternational
Oxbotica, provider of autonomous vehicle software, has announced the completion of a $47 million Series B investment. The funding will accelerate Oxbotica’s commercial deployment of its autonomy software platform across multiple industries and key markets. Oxbotica’s is deploying its autonomy software in industrial use cases in advance of rolling out in urban passenger transportation applications in the future.